Global Topical Skin Adhesive Market is expected to reach USD 1,047.60 million by 2025 from USD 607.35 million in 2018, at a CAGR of 8.1% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Access Full Report: http://databridgemarketresearch.com/reports/global-topical-skin-adhesive-market/
The global topical skin adhesive market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. global topical skin adhesive market is dominated by Ethicon U.S. LLC (Johnson & Johnson Services, Inc.), followed by Medtronic, Advanced Medical Solutions Group plc and Aesculap AG (B. Braun Melsungen AG). Other players in this market include are Pfizer, connexicon medical, Chemence Medical, Inc., Adhezion Biomedical, GluStitch Inc., Meyer-Haake GmbH, Beijing Compont Medical Devices Co., Ltd., Cartell Chemical Co., Ltd among others.
Ethicon U.S. LLC (Johnson & Johnson Services, Inc.):
Founded in 1886 and headquartered at New Brunswick, New Jersey, U.S., The company operates through three business segments, namely, Consumer, Pharmaceutical, and Medical Devices. The pharmaceutical segment offers a wide range of products for five major therapeutic applications—immunology, infectious diseases, neuroscience, oncology, and cardiovascular & metabolic diseases. The consumer segment of the company offers various products pertaining to baby care, oral care, skin care, women’s health, and wound care. The medical devices segment of the company offers various devices to be used in therapeutic areas such as orthopedic, surgical care, specialty surgery, cardiovascular care, diagnostics, diabetes care, and vision care.
Ethicon U.S. LLC is a subsidiary of Johnson& Johnson Services, Inc. which is offering the orthopedic soft tissue repair products. Johnson & Johnson has more than 265 operating companies across the United States, Europe, Western Hemisphere, Africa, and Asia-Pacific. Some of its subsidiaries include Janssen Pharmaceuticals (Belgium), Neutrogena (U.S.), Synthes (Switzerland), Cordis Corporation (U.S.), LifeScan, Inc. (U.S.), Janssen-Cilag (U.S.), McNeil Consumer Healthcare (U.S.), Janssen Biotech, Inc. (U.S.), Ortho Clinical Diagnostics (U.S.), and Mentor Worldwide LLC (U.S.).
Founded in 1949 and headquartered Minneapolis, U.S. Medtronic is the world’s largest standalone medical technology development and a global healthcare solution company. The company operates in cardiac and vascular group (cardiac rhythm and heart failure, coronary and structural heart, aortic and peripheral vascular), minimally invasive therapies group (surgical solutions and patient monitoring & recovery), restorative therapies (spine, brain therapies, speciality therapies and pain therapies), and diabetes group (intensive insulin management, non- intensive diabetes therapies, diabetes service and solutions).
The company operates in more than 155 countries worldwide with more than 260 locations in research and development, manufacturing and distribution, and education centers. The company’s regional locations are Asia Pacific, Eastern Europe, Latin America, Middle East and Africa, Central Asia, South Asia, U.K., and Western Europe. Some of its subsidiaries include Medtronic Belgium S.A. /N.V. Belgium), DantecElettronica S.r.l. (Rome), Medtronic (Shanghai) Ltd. (China), Medtronic B.V. (Netherlands), Medtronic Xomed Limited (U.K) and many more.
Advanced Medical Solutions Group Plc:
Founded in 1991 and headquartered in Cheshire, U.K. The AMS Group of companies is engaged in the development, manufacturing and distribution of wide range of surgical dressings, wound care products and medical grade materials and the medical adhesives and sutures for closure and sealing the tissue. The company operates its business in the four segments known as OEM (Original Equipment Manufacturer), branded direct, branded distributed and bulk materials. The branded direct provides the skin adhesive product for the wound closures in various surgeries.
The AMS Group has six manufacturing facilities, six sales offices in Europe, and the sales team is operating in the United States.
Aesculap AG (B. Braun Melsungen AG):
Aesculap AG operates as a subsidiary of B. Braun Melsungen AG.
The company has offices and facilities in more than 50 countries. B. Braun and its subsidiaries currently employ more than 54,000 people in more than 60 countries. Some of its subsidiaries are B. Braun Melsungen Inc. (U.S), B. Braun Medical Pvt. Ltd. (India),B. Braun Surgical GmbH (Germany), B. BraunAvitum AG (Colombia) among others.
Global Topical Skin Adhesive Market – Industry Trends and Forecast to 2027
North America Topical Skin Adhesive Market – Industry Trends and Forecast to 2027
Europe Topical Skin Adhesive Market - Industry Trends and Forecast to 2027
Asia-Pacific Topical Skin Adhesive Market – Industry Trends and Forecast to 2027